Prolactinoma and pregnancy

British Journal of Obstetrics and Gynaecology

Volumn 107, Issue 9, 2000, Pages 1064-1068

  Randeva, Harpal S ^a   Davis, Melanie ^b   Prelevic, Gordana M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CORTICOTROPIN; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOLINE DERIVATIVE; ESTROGEN; GONADOTROPIN; PROLACTIN; QUINAGOLIDE; THYROTROPIN;

CANCER THERAPY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG INDICATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; PREGNANCY; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR VOLUME;

BROMOCRIPTINE; DOPAMINE AGONISTS; FEMALE; HORMONE ANTAGONISTS; HUMANS; PITUITARY NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROLACTINOMA;

EID: 0033816709     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb11101.x     Document Type: Review

References (37)

1. Clinical and endocrine features of hyperprolactinaemic amenorrhoea
2. Prolactin pulsatility in patients with gonadal dysfunction
3. Drugs five years later: Bromocriptine
4. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhoea
5. The qadenohypophysis
6. Prevalence and presentation of hyperprolactinaemia in patients with 'functionless' pituitary tumours
7. Results of surgery in 114 patients with prolactin-screening pituitary adenomas
8. Hyperprolactinaemia in males with and without pituitary macroadenomas
9. The pituitary 'incidentaloma'
10. Hyperprolactinaemia, amenorrhoea and galactorrhoea
11. The natural history of untreated hyperprolactinaemia: A prospective analysis
12. Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement
13. Dopamine agonists and pituitary tumour shrinkage
14. Bromocriptine as primary therapy for prolactin-screening macroadenomas - Macroadenomas results of a prospective multicenter study
15. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinaemic amenorrhoea
16. Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine
17. Prolactin cells in the human pituitary: A quantitative immunocytochemical analysis
18. Pituitary gland growth during normal pregnancy: An in vivo study using magnetic resonance imaging
19. The pituitary gland in pregnancy: A clinico-pathologic and immunohistochemical study of 69 cases
20. Early differences in the endocrine profile of long and short lactational amenorrhoea
21. Effects of oestrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells
22. Outcome of pregnancy in women with pituitary adenoma
23. Pregnancy and the hyperprolactinaemic woman
24. Bromocriptine in pregnancy: Safety aspects
25. Follow up of children born of bromocriptine-treated mothers
26. Pregnancy and delivery under bromocriptine therapy
27. Long term effects of time, medical treatment and pregnancy in 176 hyperprolactinaemic women
28. Long term follow up of patients with hyperprolactinaemia
29. Prolactinomas
30. Pituitary surgery
31. Relationship between the methods of treatment for prolactinomas and the puerperal lactation
32. Primary radiotherapy of prolactinomas
33. Megavoltage pituitary irradiation in the management of prolactinomas: Long term follow up
34. Prolactinomas: Present day management
35. Prolactinomas
36. Surgery during pregnancy and fetal outcome
37. Lymphocytic hypophysitis. Review of 3 new cases and review of the literature